ASTRAZENECA has agreed a deal of up to $1.58billion to sell part of its antibiotics business to Pfizer, two years after seeing off a £69billion takeover bid from the US drugs giant.
Reuben bring you latest trend in Online Business; Insight and Ideas on how to Grow your Small and Medium Scale Business
No comments:
Post a Comment